UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Solar Aspect System of the Hard X-ray Imager Onboard ASO-S

Solar physics, 2024-09, Vol.299 (9), p.122, Article 122

2024

Volltextzugriff (PDF)

Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2024-08, Vol.332 (7), p.561

2024

Volltextzugriff (PDF)

Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition

Breast cancer research and treatment, 2024-08, Vol.206 (3), p.679-679

2024

Volltextzugriff (PDF)

Clinical Manifestation, Risk Factors, and Immune Checkpoint Inhibitor Rechallenge of Checkpoint Inhibitor-Associated Pneumonitis in Patients With Lung Cancer

Journal of immunotherapy (1997), 2024-07, Vol.47 (6), p.220-226

2024

Volltextzugriff (PDF)

Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study

Journal of thoracic oncology, 2024-06, Vol.19 (6), p.898-911

2024

Volltextzugriff (PDF)

ARTEMIS-001: Data from a phase 1a/b study of HS-20093 in patients with relapsed small cell lung cancer (SCLC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8093-8093

2024

Volltextzugriff (PDF)

Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III NSCLC (TRAILBLAZER): Efficacy, safety and feasibility of surgical conversion outcomes from a proof-of-concept, phase 2 trial

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8082-8082

2024

Volltextzugriff (PDF)

A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.8533-8533

2024

Volltextzugriff (PDF)

BPNN Based Multi-factor Synthesis Prediction Method for Coal Rock Fatigue Life

Geotechnical and geological engineering, 2024-05, Vol.42 (3), p.2093-2106

2024

Volltextzugriff (PDF)

Community assembly and microbial interactions in an alkaline vanadium tailing pond

Environmental research, 2024-04, Vol.246, p.118104-118104, Article 118104

2024

Volltextzugriff (PDF)

Amino acids analysis reveals serum methionine contributes to diagnosis of the Kawasaki disease in mice and children

Journal of pharmaceutical and biomedical analysis, 2024-02, Vol.239, p.115873-115873, Article 115873

2024

Volltextzugriff (PDF)

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial

Journal of thoracic oncology, 2024-02, Vol.19 (2), p.314-324

2024

Volltextzugriff (PDF)

Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats

Bioanalysis, 2024, Vol.16 (10), p.461-473

2024

Volltextzugriff (PDF)

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

Thoracic cancer, 2023-09, Vol.14 (26), p.2715-2731

2023

Volltextzugriff (PDF)

Tumor‐derived exosomal miR‐148b‐3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion

Thoracic cancer, 2023-06, Vol.14 (16), p.1477-1491

2023

Volltextzugriff (PDF)

Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.9014-9014

2023

Volltextzugriff (PDF)

A study to evaluate the safety, tolerability, and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1–selected non–small-cell lung cancer (NSCLC): Updated efficacy and safety results

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e14578-e14578

2023

Volltextzugriff (PDF)

The hepatoprotective effect of aspirin on carbon tetrachloride‑induced hepatic fibrosis via inhibition of TGFβ‑1 pathway and pro‑inflammatory cytokines IL‑1β and COX‑2 in rats

Experimental and therapeutic medicine, 2023-05, Vol.25 (5), Article 232

2023

Volltextzugriff (PDF)

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

Thoracic cancer, 2023-04, Vol.14 (12), p.1102-1117

2023

Volltextzugriff (PDF)

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer

International journal of gynecological pathology, 2023-01, Vol.42 (1), p.11-20

2023

Volltextzugriff (PDF)

Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells

Evidence-based complementary and alternative medicine, 2023, Vol.2023 (1), p.1307323-1307323

2023

Volltextzugriff (PDF)

Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.435-435

2022

Volltextzugriff (PDF)

CircPVT1 up‐regulation attenuates steroid‐induced osteonecrosis of the femoral head through regulating miR‐21‐5p‐mediated Smad7/TGFβ signalling pathway

Journal of cellular and molecular medicine, 2021-05, Vol.25 (10), p.4608-4622

2021

Volltextzugriff (PDF)

[Corrigendum] Telocinobufagin inhibits the epithelial‑to‑mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Oncology letters, 2021-04, Vol.21 (4), p.1, Article 242

2021

Volltextzugriff (PDF)

Erratum: Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Oncology letters, 2021-04, Vol.21 (4), p.242-242

2021

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Aktive Filter

KollektionWK Lippincott Williams & Wilkins–Connect here FIRST to enable access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(68)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(78)
Berichte
(1)

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The Solar Aspect System of the Hard X-ray Imager Onboard ASO-S

Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial

Expression of Concern to: RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial–mesenchymal transition

Clinical Manifestation, Risk Factors, and Immune Checkpoint Inhibitor Rechallenge of Checkpoint Inhibitor-Associated Pneumonitis in Patients With Lung Cancer

Ficonalkib (SY-3505) in Advanced ALK-Positive NSCLC: A Multicenter, Open-Label, Single-Arm, Phase 1/2 Study

ARTEMIS-001: Data from a phase 1a/b study of HS-20093 in patients with relapsed small cell lung cancer (SCLC)

Neoadjuvant SHR-1701 with or without chemotherapy in unresectable stage III NSCLC (TRAILBLAZER): Efficacy, safety and feasibility of surgical conversion outcomes from a proof-of-concept, phase 2 trial

A phase Ib/IIa trial to evaluate the safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced NSCLC

BPNN Based Multi-factor Synthesis Prediction Method for Coal Rock Fatigue Life

Community assembly and microbial interactions in an alkaline vanadium tailing pond

Amino acids analysis reveals serum methionine contributes to diagnosis of the Kawasaki disease in mice and children

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of YK-029A in Treatment-Naive Patients With Advanced NSCLC Harboring EGFR Exon 20 Insertion Mutations: A Phase 1 Trial

Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats

Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma

Tumor‐derived exosomal miR‐148b‐3p mediates M2 macrophage polarization via TSC2/mTORC1 to promote breast cancer migration and invasion

Safety and preliminary efficacy of YK-029A, a novel EGFR TKI, in patients with advanced NSCLC harboring ex20ins, T790M or rare mutations

A study to evaluate the safety, tolerability, and efficacy of IBI939 in combination with sintilimab in patients with previously untreated locally advanced unresectable or metastatic PD-L1–selected non–small-cell lung cancer (NSCLC): Updated efficacy and safety results

The hepatoprotective effect of aspirin on carbon tetrachloride‑induced hepatic fibrosis via inhibition of TGFβ‑1 pathway and pro‑inflammatory cytokines IL‑1β and COX‑2 in rats

Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors

The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer

Inhibitory Effect and Mechanism of Ursolic Acid on Cisplatin-Induced Resistance and Stemness in Human Lung Cancer A549 Cells

Toripalimab plus bevacizumab as first-line treatment for advanced hepatocellular carcinoma: A single-arm phase II study

CircPVT1 up‐regulation attenuates steroid‐induced osteonecrosis of the femoral head through regulating miR‐21‐5p‐mediated Smad7/TGFβ signalling pathway

[Corrigendum] Telocinobufagin inhibits the epithelial‑to‑mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Erratum: Telocinobufagin inhibits the epithelial-to-mesenchymal transition of breast cancer cells through the PI3K/Akt/Snail signaling pathway

Aktive Filter

Suchergebnisse filtern